PressJanuary 16, 2024 Red Light Holland Receives Building Permit for AEM Farms 80,000 Square Foot Mushroom Farm, Adding Substantial Future Production Capacity
PressJanuary 11, 2024 PSYC’s CEO Provides Detailed Update on the State of the Company in Newly Released Podcast Recording
PressJanuary 11, 2024 Cybin Announces Positive Topline Data from Phase 1 Studies of Proprietary Deuterated DMT Molecules CYB004 and SPL028
PressJanuary 11, 2024 Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
PressJanuary 11, 2024 Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement
PressJanuary 11, 2024 BRAINWeek 2024 to Feature Three Nationally-Acclaimed, Energizing Keynote Speakers Who Will Address the Field’s Most Relevant Topics on Brain Health.
PressJanuary 5, 2024 MAPS Public Benefit Corporation Announces Oversubscribed Series A Financing and Renames to Lykos Therapeutics
PressJanuary 4, 2024 Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
PressJanuary 4, 2024 Cybin Highlights Recent Topline Results and Outlines Key Upcoming Milestones Across its Clinical Development Programs
PressJanuary 4, 2024 SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments
PressJanuary 4, 2024 Optimi Health Granted Precursor Licence To Formulate MDMA And Completes Encapsulation Of 40mg And 60mg Dosage Formats
PressJanuary 4, 2024 atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics
PressJanuary 2, 2024 atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)
PressJanuary 2, 2024 BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001
PressJanuary 2, 2024 Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia
PressDecember 22, 2023 Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia
PressDecember 21, 2023 Revive Therapeutics Announces Results of Annual General and Special Meeting of Shareholders
